These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18568705)

  • 21. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognition-enhancing effects of donepezil in traumatic brain injury.
    Khateb A; Ammann J; Annoni JM; Diserens K
    Eur Neurol; 2005; 54(1):39-45. PubMed ID: 16118495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: a critical review.
    Writer BW; Schillerstrom JE
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):362-70. PubMed ID: 19996244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
    J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic treatment of cognitive deficits: a case study.
    Weinberg RM; Auerbach SH; Moore S
    Brain Inj; 1987; 1(1):57-9. PubMed ID: 3454673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
    Noble JM; Hauser WA
    Neurology; 2007 May; 68(20):1749; author reply 1750. PubMed ID: 17502565
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of donepezil in the treatment of cognitive impairments of moderate traumatic brain injury.
    Foster M; Spiegel DR
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):106. PubMed ID: 18305293
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
    Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances].
    Litvinenko IV; Emelin AIu; Vorob'ev SV; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):60-6. PubMed ID: 21311490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 34. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.
    El Sayed I; Zaki A; Fayed AM; Shehata GM; Abdelmonem S
    Neurosurg Rev; 2018 Apr; 41(2):427-438. PubMed ID: 27539610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.
    Ferreri F; Agbokou C; Gauthier S
    J Psychiatry Neurosci; 2006 Nov; 31(6):369-76. PubMed ID: 17136214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].
    Riós-Romenets S; Castaño-Monsalve B; Bernabeu-Guitart M
    Rev Neurol; 2007 Nov 1-15; 45(9):563-70. PubMed ID: 17979087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
    Sharma T; Reed C; Aasen I; Kumari V
    Schizophr Res; 2006 Jul; 85(1-3):73-83. PubMed ID: 16797163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selection of neuromethabolic drug in severe brain injury].
    Zaĭtsev OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):66-9. PubMed ID: 21246892
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I.
    Chouinard S; Sepehry AA; Stip E
    Clin Neuropharmacol; 2007; 30(3):169-82. PubMed ID: 17545751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.